OrbiMed

About

OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.

101 - 250

Highlights

Details

Industries: Angel Investment,Financial Services,Health Care
Founded date: Jan 1, 1989
Number Of Employee: 101 - 250
Operating Status: Active
Investor Type: PE

OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Investments

Number of Investments

Number of Lead Investments

65

26

OrbiMed has made 65 investments. Their most recent investment was on Dec 7, 2022, when Apogee Therapeutics raised $149M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 7, 2022 Apogee Therapeutics	Series B	$149M	Biotechnology	—
Nov 14, 2022 MBX Biosciences	Series B	$115M	Biotechnology	—
Oct 11, 2022 Treeline Biosciences	Series A	$261.26M	Biotechnology	—
Sep 12, 2022 Adaptive Biotechnologies	Post-IPO Debt	$125M	Biotechnology	Yes
Jun 30, 2022 X4 Pharmaceuticals	Post-IPO Equity	$55M	Biotechnology	—